TMEM127Screening in a Large Cohort of Patients with Pheochromocytoma and/or Paraganglioma
Author(s) -
Nasséra Abermil,
Marine Guillaud-Bataille,
Nelly Burnichon,
Annabelle Vénisse,
Philippe Manivet,
Laurence Guignat,
D. Drui,
M Chupin,
C. Josseaume,
Hélène Affres,
PierreFrançois Plouin,
Jérôme Bertherat,
Xavier Jeunemaı̂tre,
AnnePaule GimenezRoqueplo
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-3360
Subject(s) - sdhd , pheochromocytoma , sdhb , paraganglioma , medicine , cohort , germline mutation , gene , gene mutation , multiplex ligation dependent probe amplification , genetics , mutation , oncology , gastroenterology , pathology , biology , exon
TMEM127 is a novel pheochromocytoma (PCC) susceptibility gene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom